Huma
Huma is a medtech startup and it aims to transform healthcare and research globally. Its digital ‘hospital at home’ and decentralised clinical trial platform better enable patients, clinicians, researchers, and healthcare systems to keep tabs and be up to date on what’s happening. It uses real-time health data from smartphones in order to do so.
Huma has raised €181M across 2 funding rounds from 10 investors, most recently a Series D+ round in Jul 2024. Based in UK; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€181M
€180,659,460
Funding rounds
2
Investors
10
distinct backers
Active since
2021-05
latest 2024-07
Funding by year
EUR raised per yearHuma — funding by year — interactive chart.
Data table
| Huma — funding by year | |
|---|---|
| 2021 | €107M |
| 2024 | €73M |
Signals
High confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-16 | Series D+ | €73M | AstraZeneca,Hat Technology Fund,Hitachi Ventures,Leaps by Bayer | View deal → |
| 2021-05-12 | Series C | €107M | HAT Technology & Innovation Fund,Hitachi Ventures,Leaps by Bayer,Michael Diekmann,Nikesh Arora,Samsung Next+2 more | View deal → |
Investors
10Acquisitions
1- Aluna2025
Related news
- https://t.co/4V9EV2hnuvuktech.news · 2021-05
- tech.eu
Similar companies
same sector or countryGlobal coverage: FundingData